Home › Compare › NEVPF vs VICI

NEVPF vs VICI: Dividend Comparison 2026

NEVPF yields 7142.86% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEVPF wins by $2020155342665730.25M in total portfolio value
10 years
NEVPF
NEVPF
● Live price
7142.86%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2020155342665731.25M
Annual income
$1,966,011,161,323,515,200,000.00
Full NEVPF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — NEVPF vs VICI

📍 NEVPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEVPFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEVPF + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NEVPF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEVPF
Annual income on $10K today (after 15% tax)
$607,142.86/yr
After 10yr DRIP, annual income (after tax)
$1,671,109,487,124,987,800,000.00/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, NEVPF beats the other by $1,671,109,487,124,987,200,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEVPF + VICI for your $10,000?

NEVPF: 50%VICI: 50%
100% VICI50/50100% NEVPF
Portfolio after 10yr
$1010077671332866.13M
Annual income
$983,005,580,661,757,800,000.00/yr
Blended yield
97.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

NEVPF
No analyst data
Altman Z
-0.7
Piotroski
2/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEVPF buys
0
VICI buys
0
No recent congressional trades found for NEVPF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEVPFVICI
Forward yield7142.86% ✓6.52%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$2020155342665731.25M ✓$966.2K
Annual income after 10y$1,966,011,161,323,515,200,000.00 ✓$607,376.13
Total dividends collected$2016528271361529.00M ✓$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NEVPF vs VICI ($10,000, DRIP)

YearNEVPF PortfolioNEVPF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$724,986$714,285.71$11,361$941.49+$713.6K → NEVPF
2$49,172,645$48,396,910.17$13,320$1,481.32+$49.16M → NEVPF
3$3,120,421,331$3,067,806,600.72$16,284$2,405.01+$3120.41M → NEVPF
4$185,281,229,916$181,942,379,091.82$21,040$4,071.78+$185281.21M → NEVPF
5$10,294,691,143,508$10,096,440,227,497.77$29,209$7,285.49+$10294691.11M → NEVPF
6$535,299,070,050,255$524,283,750,526,701.75$44,443$14,006.51+$535299070.01M → NEVPF
7$26,050,796,629,539,330$25,478,026,624,585,550.00$75,822$29,512.55+$26050796629.46M → NEVPF
8$1,186,669,129,317,434,600$1,158,794,776,923,827,700.00$148,733$69,726.75+$1186669129317.29M → NEVPF
9$50,602,038,637,584,920,000$49,332,302,669,215,270,000.00$344,394$189,413.75+$50602038637584.57M → NEVPF
10$2,020,155,342,665,731,300,000$1,966,011,161,323,515,200,000.00$966,234$607,376.13+$2020155342665730.25M → NEVPF

NEVPF vs VICI: Complete Analysis 2026

NEVPF — Stock

Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Full NEVPF Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this NEVPF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEVPF vs SCHDNEVPF vs JEPINEVPF vs ONEVPF vs KONEVPF vs MAINNEVPF vs NNNNEVPF vs EPRTNEVPF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.